Equity · Financial Services
CME
NASDAQCME Group (CME)
The line runs 274 USD on 10 September through 305.94 USD on 6 November, on a scale from 260 to 320. Days the market did not trade hold the previous close, flat.
- Market cap
- 110.4B USD
- P/E (TTM)
- 25.1
- Revenue, year to Dec 2025
- 6.5B USD
- EPS, diluted, year to Dec 2025
- 11.16 USD
- 52-week range
- 218.63 USD – 326.40 USD
- Avg volume
- 105.4K
- Mentions, 30 days
- 45
- Net sentiment
- +0.06
as of Nov 6, 2026
Have CME Group (CME) insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, CME Group insiders reported 6 open-market sales and 1 purchase (SEC Form 4).
Form 4, 90 days to 9 Nov 2026, newest reported trade 2 Nov 2026
Buys 1Sells 6Net sold $9.47MOther filings 32
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 02 Nov 2026 | Winkler JulieSr MD Chief Commercial Officer | Sell | 10,079 | 3.1M USD |
| 02 Nov 2026 | SIEGEL HOWARD JDirector | Sell | 2,000 | 606K USD |
| 27 Oct 2026 | Cutinho SunilChief Information Officer | Sell | 5,000 | 1.5M USD |
| 22 Oct 2026 | GEPSMAN MARTIN JDirector | Sell | 400 | 121K USD |
| 25 Sep 2026 | SHEPARD WILLIAM RDirector | Buy | 293 | 79K USD |
| 14 Sep 2026 | Cook Elizabeth ADirector | Sell | 500 | 140K USD |
| 10 Sep 2026 | DUFFY TERRENCE AChairman and CEO | Sell | 15,000 | 4.1M USD |
| Bought | 1 open-market purchase | 293 | $79K | |
| Sold | 6 open-market sales | 32,979 | $9.55M |
32 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 16 Sep 2026 | Vroman KenChief Transformation Officer | Tax withheld | 308 | 84K USD |
| 16 Sep 2026 | Sammann DerekSr MD Gl Hd Commodities Mkts | Tax withheld | 359 | 98K USD |
| 16 Sep 2026 | Cutinho SunilChief Information Officer | Tax withheld | 359 | 98K USD |
| 16 Sep 2026 | Tobin Jack JMD Chief Accounting Officer | Tax withheld | 51 | 14K USD |
| 16 Sep 2026 | Winkler JulieSr MD Chief Commercial Officer | Tax withheld | 359 | 98K USD |
| 16 Sep 2026 | Dennis Michael G.Global Head of Fixed Income | Tax withheld | 274 | 75K USD |
| 16 Sep 2026 | Sprague SuzanneCOO & Global Head of Clearing | Tax withheld | 308 | 84K USD |
| 16 Sep 2026 | Fitzpatrick LynnePresident and CFO | Tax withheld | 359 | 98K USD |
| 16 Sep 2026 | McCourt Timothy FrancisSr MD Global Head Equity & FX | Tax withheld | 364 | 99K USD |
| 16 Sep 2026 | Marchese John CliffordSr MD, General Counsel | Tax withheld | 44 | 12K USD |
| 15 Sep 2026 | DUFFY TERRENCE AChairman and CEO | Award | 21,812 | 6.0M USD |
| 15 Sep 2026 | Vroman KenChief Transformation Officer | Award | 2,592 | 713K USD |
Showing the 12 most recent of 32 compensation filings in this window. The figures above count all of them.
Which funds hold CME Group (CME)?
1 of the 45 institutional funds we track reported a CME Group position for the quarter ended 30 Sep 2026 — a combined 365K USD; the latest of those filings landed 06 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Held (±25%) | 1,392 | 365K USD | −1.9% |
Have members of Congress traded CME Group (CME)?
The most recent congressional trade disclosed in CME Group is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 09 Jan 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 09 Jan 2026 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Purchase | 1K USD–15K USD | 35 days |
| 13 Nov 2025 | Julie Johnsonhouse · Democrat–TX | Sale | 1K USD–15K USD | 28 days |
| 23 Sep 2025 | Val T. Hoylehouse · Democrat–OR | Sale | 1K USD–15K USD | 17 days |
| 14 Aug 2025 | Julie Johnsonhouse · Democrat–TX | Sale | 1K USD–15K USD | 28 days |
| 11 Aug 2025 | Julie Johnsonhouse · Democrat–TX | Purchase | 1K USD–15K USD | 31 days |
| 22 Jul 2025 | Julie Johnsonhouse · Democrat–TX | Purchase | 1K USD–15K USD | 23 days |
| 21 May 2025 | Val T. Hoylehouse · Democrat–OR | Purchase | 1K USD–15K USD | 114 days |
| 08 Apr 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Purchase | 1K USD–15K USD | 30 days |
What has been filed or recorded for CME Group (CME)?
The filings we hold for CME Group, newest first: 7 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,121 shares | 311K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 175 shares | 48K USD notional · <0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 17 shares | 5K USD notional · <0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 122 shares | 33K USD notional · <0.001% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 110 shares | 29K USD notional · <0.001% of shares out |
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 120 shares | 32K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 2.89 USD | Revenue $1.74B |
| 30 Sep 2026 | Financials | Total assets | 192.1B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 26.6B USD | at period end |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 57,703 shares | 15.3M USD notional · 0.016% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 2.88 USD | Revenue $1.71B |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 3.18 USD | Revenue $1.88B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 11.16 USD | Revenue $6.52B |
| 31 Dec 2025 | Financials | Revenue | 6.5B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 4.1B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 11.16 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 2.49 USD | Revenue $1.54B |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 2.81 USD | Revenue $1.69B |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 2.62 USD | Revenue $1.64B |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 9.67 USD | Revenue $6.13B |
What is Reddit saying about CME Group (CME)?
Reddit mentioned CME 45 times in the 30 days to 8 November 2026, across 6 of the communities we track. All of them were scored for sentiment: 49% read bullish, 9% bearish and 42% neither. Reddit data updated 8 November 2026.
30-day window, Method
Mentions, 30 days 45Bullish 49%Bearish 9%Communities 6Against the market −5 points
How do Reddit mentions of CME Group (CME) compare with its price?
Share ↗
Is the Reddit crowd more bullish on CME Group than on the market?
CME reads 33% bullish, 21 points below the market (54%). Over 90 days the gap has run from -38 to +37 points.
- CME
- 33%
- bullish, 8 Nov
- Market
- 54%
- bullish, all Reddit, 8 Nov
- Gap
- −21 pts
- CME against market
Where CME Group (CME) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 49% | 22 | +0.06 |
| r/commodities | 24% | 11 | +0.06 |
| r/stocks | 11% | 5 | −0.08 |
| r/options | 7% | 3 | +0.26 |
| r/cryptocurrency | 4% | 2 | +0.04 |
| r/investing | 4% | 2 | +0.16 |
CME Group (CME): frequently asked questions
What did CME Group shares close at?
CME Group closed at 305.94 USD on 6 Nov 2026, down 0.41% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is CME Group’s market cap?
CME Group is worth 110.4B USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is CME Group’s P/E ratio?
CME Group has a price-to-earnings ratio of 25.1, as of 6 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is CME Group’s revenue?
CME Group reported revenue of 6.5B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have CME Group insiders bought or sold shares recently?
In the 90 days to 9 Nov 2026, CME Group insiders reported 6 open-market sales and 1 purchase (SEC Form 4). A further 32 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own CME Group?
1 of the 45 funds we track reported a CME Group position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds
Have members of Congress traded CME Group?
Yes. 22 trades in CME Group appear in the congressional disclosures we hold; the latest is a purchase by Gilbert Ray Cisneros, Jr. (House, CA) dated 9 Jan 2026, filed 13 Feb 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did CME Group last report earnings?
CME Group last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 2.89 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about CME Group?
CME Group was mentioned 9 times in the last 7 days across the finance subreddits we track, and 45 times over the trailing 30 days. Of the 45 mentions scored for sentiment, 49% read bullish and 9% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings